| Similar Articles |
|---|
 |
BusinessWeek
September 9, 2010
Michelle Cortez |
Coming Soon: Dissolvable Stents New stents from Abbott Labs and others appear to reduce the risk of blood clots   |
Chemistry World
November 25, 2010
Hayley Birch |
Designing safer stents for heart patients A study by UK researchers provides insights into how the body reacts to the metal stents used to wedge open blocked blood vessels in heart patients. |
Chemistry World
December 4, 2007
Richard Van Noorden |
Polymer Chemistry Tackles Implant Concerns Advances in polymer chemistry could help resolve safety concerns surrounding body implants, such as stents to hold open clogged arteries, scientists heard at the Materials Research Society Fall meeting. |
The Motley Fool
December 13, 2006
Stephen Albainy-Jenei |
The Latest Standpoint on Stents A panel of experts reaches mixed conclusions on the safety and effectiveness of drug-coated stents. Investors, take note. |
The Motley Fool
October 31, 2006
Michael P. Cecil |
An Opening for Plavix New data suggesting problems with drug-eluting stents may translate into more sales of the blood thinner Plavix and fewer sales of the stents. Investors, take note. |
Managed Care
June 2006
Tom Pope |
Hard to Curb Overuse of Drug-Eluting Stents Health plans find themselves paying for the latest and greatest stent without any control over usage. Even bare-metal stents may be overused. |
BusinessWeek
October 29, 2007
Arlene Weintraub |
Medtronic's Uncertain Endeavor The drug-coated stent might have made up for Medtronic's recent product recall, but renewed scrutiny of the device has executives scaling back expectations |
The Motley Fool
October 25, 2007
Brian Orelli |
Time to Invest in Stents? Stent devices have seen slumping sales over the last few years. Is it time now to invest in the companies that produce them? |
The Motley Fool
March 29, 2007
Michael P. Cecil |
Stents on Trial New study results could affect stent sales -- at least in the short term. |
BusinessWeek
August 8, 2005
Amy Barrett |
BW 50: In A Bind Over Stents Safety concerns about drug-coated stents from Johnson & Johnson and Boston Scientific could open the way for rivals. |
BusinessWeek
October 29, 2007
Arlene Weintraub |
Heart Trouble The tiny stent sparked a lucrative industry - and made Dr. Samin Sharma a star. Then questions arose about the device's safety and efficacy. |
BusinessWeek
October 9, 2006
John Carey |
"No One Wanted To Hear" Renu Virmani warned that, over time, some drug-coated stents could lead to fatal clots. |
The Motley Fool
May 27, 2010
Brian Orelli |
Ever-Evolving Stent Technology (and How to Profit From It) Stay ahead of the curve. |
Managed Care
July 2003
Thomas Morrow |
Drug-Eluting Stents To Transform Cardiovascular Medicine By reducing restenosis, these devices will save managed care money. |
BusinessWeek
July 18, 2005
John Carey |
Is Heart Surgery Worth It? Physicians are questioning whether bypasses and angioplasties necessarily prolong patients' lives. |
Reactive Reports
Issue 43
David Bradley |
Polymer Technology Saves Face PolyHap readily bonds with bone with no adverse side effects. The material might ultimately replace titanium in prosthetics and bone repair surgery. The material is currently undergoing clinical trials in Moscow. |
The Motley Fool
March 27, 2008
Brian Orelli |
Tougher Rules Could Help Stent Makers The FDA has finally issued draft guidance on the minimum requirements that it thinks companies need to fulfill to get drug-eluting stents approved. |
Reactive Reports
Issue 52
David Bradley |
Corrosion Isn't All Bad The chemical corrosion of metal surfaces is not all bad and might be exploited to produce useful nanoscale surface features with potential technological applications in catalysis, sensors, and other areas. |
The Motley Fool
June 1, 2005
Stephen D. Simpson |
Stent Wars: Revenge of the Bypass A new study supports a long-held belief that bypass surgery is better than using stents. What does it mean for stent makers and investors? |
The Motley Fool
May 28, 2009
Brian Orelli |
Boston Scientific Back in an Atomic Way Can its tiny stent save the day? |
The Motley Fool
December 13, 2006
Matthew Crews |
Less Support for Drug-Eluting Stents? The FDA responds to a recent controversy. The regulator's stance represents a good-faith-take on the newer stents, which is good news for drug companies. |
Chemistry World
November 7, 2011
Kate McAlpine |
Spotting Artery Damage Before a Heart Attack An international team of medical researchers has developed a way to perform a check up on an artery's physical structure and molecular markers of ill health by coupling a catheter with imaging technology. |
BusinessWeek
June 20, 2005
Spencer E. Ante |
Powering Through Clogged Arteries FoxHollow's SilverHawk is a promising alternative to stents and bypass surgery. |
Health
July 2007
Curt Pesmen |
Surgery to Avoid #3: Angioplasty A new study has found that heart medication is just as effective as this invasive surgery. |
